Latest Breaking News On - Flow nebulizer system - Page 1 : comparemela.com

Savara to Present at the Citizens JMP Life Sciences Conference

Savara to Present at the Citizens JMP Life Sciences Conference
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Pharma gmbLang schwarzFlow nebulizer systemSavara stock

Savara Reports Second Quarter Financial Results and Provides Business Update

10.08.2023 - Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the second quarter ending June 30, 2023 and provided a business update. “The Company continues .

Pharma gmbSavara incSecond quarter financial resultsFlow nebulizer systemPrivate securities litigation reformConsolidated statementsSavara stock

Avalyn Pharma Publishes Phase 1b ATLAS Results Demonstrating Stabilization of Lung Function at 24 and 48 Weeks with AP01 and Favorable Safety Profile

Avalyn Pharma Publishes Phase 1b ATLAS Results Demonstrating Stabilization of Lung Function at 24 and 48 Weeks with AP01 and Favorable Safety Profile
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomLyn baranowskiAvalyn pharmaMarc schneebaumPbritish thoracic societyAvalyn pharma incAline sherwood scienta communicationsAvalyn pharma inc mediaWall streetPharma incBritish thoracicAlex westInterstitial lung disease leadFlow nebulizer systemPirfenidone solution

Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

14.09.2022 - Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to three new employees. On September 13, 2022, the Compensation Committee of Savara s Board .

Pharma gmbFlow nebulizer systemSavara stock

Savara Inc : Savara Presented Data at the European Respiratory Society (ERS) International Congress 2022

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented three posters at the ERS International Congress 2022 that took place September

Comunidad autonoma de catalunaPharma gmbAnne ericksonInternational congressSavara incEfficacy measuresAutoimmune pulmonary alveolar proteinosisWho required whole lungRespiratory questionnaire totalInhaled molgramostimPrimary endpointEuropean respiratory journalFlow nebulizer systemVice president